Skip to content

Pharmacogenetic studies of the pharmacokinetics and the analgesic effect of sufentanil for postoperative analgesia

Pharmacogenetic studies of the pharmacokinetics and the analgesic effect of sufentanil for postoperative analgesia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-12002454
Enrollment
Unknown
Registered
2012-07-22
Start date
2012-08-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with abdominal cancers who need surgery and use sufentanil for postoperative analgesiause

Interventions

Total:genotyping

Sponsors

Hunan Provincial Tumor Hospital (Xiangya Tumor Hospital, Central South University)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. at least 18 years old, and BMI is within +/-20% of the normal range; 2. have abdominal cancers, need surgery treatment, and agree to use sufentanil for postoperative analgesia; 3. Patient or their guardians agree to participant the study, and has signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. preoperative history of chronic pain; neuropsychiatric disorders, can not correctly understand the pain scoring rules; 2. severe cardiovascular diseases, kidney or liver dysfunction, diabetes, pregnancy or breast-feeding; 3. alcoholism, opiate addiction,or long-term use of analgesic medication; 4. preoperative drug (7 days) or food history (3 days) that could induce or inhibit CYP3A4 enzyme expression. The drugs and food include: erythromycin, clarithromycin, alcohol, chocolate, caffeine, soft drink containing grape juice, verapamil, rifampicin, phenytoin,itraconazole, dexamethasone, phenobarbital, and carbamazepine.

Design outcomes

Primary

MeasureTime frame
CYP3A4;ABCB1;OPRM1;

Countries

China

Contacts

Public ContactJing-Shi Liu
743655404@qq.com+86 13875918968

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026